Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127106231 | 12710623 | 1 | I | 20160819 | 20160829 | 20160902 | 20160902 | PER | US-CELGENEUS-USA-2016087634 | CELGENE | 78.39 | YR | M | Y | 70.37000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127106231 | 12710623 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | A2238A | 21880 | 20 | MG | CAPSULES | |||||
127106231 | 12710623 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | U | A2238A | 21880 | 20 | MG | CAPSULES | |||||
127106231 | 12710623 | 3 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Unknown | U | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127106231 | 12710623 | 1 | Plasma cell myeloma |
127106231 | 12710623 | 3 | Parkinson's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127106231 | 12710623 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127106231 | 12710623 | Dizziness | |
127106231 | 12710623 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127106231 | 12710623 | 1 | 20160805 | 20160812 | 0 | |
127106231 | 12710623 | 2 | 20160819 | 0 | ||
127106231 | 12710623 | 3 | 20160805 | 0 |